THCB.F Stock Overview
Produces and sells medical and recreational cannabis in Canada. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
THC Biomed Intl Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.000001 |
| 52 Week High | CA$0.034 |
| 52 Week Low | CA$0.000001 |
| Beta | 0 |
| 11 Month Change | -99.90% |
| 3 Month Change | -99.99% |
| 1 Year Change | -99.99% |
| 33 Year Change | -100.00% |
| 5 Year Change | -100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| THCB.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | 2.0% |
| 1Y | -100.0% | 13.7% | 32.4% |
Return vs Industry: THCB.F underperformed the US Pharmaceuticals industry which returned 13.7% over the past year.
Return vs Market: THCB.F underperformed the US Market which returned 32.4% over the past year.
Price Volatility
| THCB.F volatility | |
|---|---|
| THCB.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.9% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: THCB.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine THCB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | n/a | John Miller | thcbiomed.com |
THC Biomed Intl Ltd. produces and sells medical and recreational cannabis in Canada. It offers cannabis beverage shots, gummies, and biscuits under the THC KISS brand names, as well as pure cannabis sticks. The company was founded in 2012 and is headquartered in Kelowna, Canada.
THC Biomed Intl Ltd. Fundamentals Summary
| THCB.F fundamental statistics | |
|---|---|
| Market cap | US$2.33m |
| Earnings (TTM) | -US$3.67m |
| Revenue (TTM) | US$2.23m |
0.0x
P/S Ratio0.0x
P/E RatioIs THCB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| THCB.F income statement (TTM) | |
|---|---|
| Revenue | CA$2.23m |
| Cost of Revenue | CA$3.39m |
| Gross Profit | -CA$1.16m |
| Other Expenses | CA$2.51m |
| Earnings | -CA$3.67m |
Last Reported Earnings
Apr 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did THCB.F perform over the long term?
See historical performance and comparison